AiCure, a pioneer in clinical trial monitoring and patient engagement, will debut its innovative H.Code platform at the DPHARM conference. This technology combines computer vision, communication tools, and analytics to enhance site teams’ understanding of participant behavior.
H.Code extends beyond adherence monitoring, enabling the development of digital assessments that connect behavior to disease and treatment outcomes, paving the way for precision medicine.
AiCure CEO Ed Ikeguchi’s presentation on “Simplifying Trial Participation” will showcase how a single platform can streamline processes for participants, sites, and sponsors.
AiCure encourages DPHARM attendees to explore H.Code’s potential in Booth #46.
Furthermore, Josh Wilson has been promoted to Chief Operating Officer (COO). With decades of experience in clinical research organizations (CROs), Wilson will lead product management and operations, implementing strategies to enhance AiCure’s mission of revolutionizing clinical trials through AI-powered solutions.
Ikeguchi expressed confidence in Wilson’s abilities: “Josh’s leadership and operational expertise have proven invaluable. His promotion reflects our trust in his guidance as AiCure continues to grow and innovate.”
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
